Xenglu Met XR 12.5/1000mg Tablet – for Maximum Diabetes & Cardio-Renal Protection
Xenglu Met XR 12.5/1000mg Tablet – for Maximum Diabetes & Cardio-Renal Protection
Xenglu Met XR 12.5/1000mg Tablet – for Maximum Diabetes & Cardio-Renal Protection
Description
Xenglu Met XR 12.5/1000mg Tablet – Ultimate Once-Daily Dual Therapy with Extended-Release Power
Xenglu Met XR 12.5/1000mg Tablet combines empagliflozin 12.5mg (SGLT2 inhibitor) with metformin extended-release 1000mg in a single, high-performance tablet. This maximum-strength, extended-release formula delivers intensive 24-hour glucose control through two proven pathways while providing superior cardiovascular protection, slows diabetic kidney disease progression, promotes greater weight loss, and lowers blood pressure. Perfect for patients with established heart disease, chronic kidney disease, or those needing aggressive A1C reduction with the convenience and stomach-friendly benefits of once-daily extended-release dosing.
